BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 38538643)

  • 1. Hypoxia drives shared and distinct transcriptomic changes in two invasive glioma stem cell lines.
    Marallano VJ; Ughetta ME; Tejero R; Nanda S; Ramalingam R; Stalbow L; Sattiraju A; Huang Y; Ramakrishnan A; Shen L; Wojcinski A; Kesari S; Zou H; Tsankov AM; Friedel RH
    Sci Rep; 2024 Mar; 14(1):7246. PubMed ID: 38538643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
    Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R
    Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene signatures of quiescent glioblastoma cells reveal mesenchymal shift and interactions with niche microenvironment.
    Tejero R; Huang Y; Katsyv I; Kluge M; Lin JY; Tome-Garcia J; Daviaud N; Wang Y; Zhang B; Tsankova NM; Friedel CC; Zou H; Friedel RH
    EBioMedicine; 2019 Apr; 42():252-269. PubMed ID: 30952620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro-inflammatory gene expression in solid glioblastoma microenvironment and in hypoxic stem cells from human glioblastoma.
    Tafani M; Di Vito M; Frati A; Pellegrini L; De Santis E; Sette G; Eramo A; Sale P; Mari E; Santoro A; Raco A; Salvati M; De Maria R; Russo MA
    J Neuroinflammation; 2011 Apr; 8():32. PubMed ID: 21489226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quiescent stem cell marker genes in glioma gene networks are sufficient to distinguish between normal and glioblastoma (GBM) samples.
    Mukherjee S
    Sci Rep; 2020 Jul; 10(1):10937. PubMed ID: 32616845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FAT1 modulates EMT and stemness genes expression in hypoxic glioblastoma.
    Srivastava C; Irshad K; Dikshit B; Chattopadhyay P; Sarkar C; Gupta DK; Sinha S; Chosdol K
    Int J Cancer; 2018 Feb; 142(4):805-812. PubMed ID: 28994107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres.
    Bar EE; Lin A; Mahairaki V; Matsui W; Eberhart CG
    Am J Pathol; 2010 Sep; 177(3):1491-502. PubMed ID: 20671264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development.
    Kucharzewska P; Christianson HC; Welch JE; Svensson KJ; Fredlund E; Ringnér M; Mörgelin M; Bourseau-Guilmain E; Bengzon J; Belting M
    Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7312-7. PubMed ID: 23589885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Expression of Hypoxia-Related Genes in Primary Brain Tumors and Correlation with Clinicopathologic Data.
    Bayat S; Mamivand A; Khoshnevisan A; Maghrouni A; Shabani S; Raouf MT; Yaseri M; Saffar H; Tabrizi M
    World Neurosurg; 2021 Oct; 154():e465-e472. PubMed ID: 34303851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analyses identify molecular signature of MRI-classified SVZ-associated glioblastoma.
    Lin CA; Rhodes CT; Lin C; Phillips JJ; Berger MS
    Cell Cycle; 2017 Apr; 16(8):765-775. PubMed ID: 28278055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knock down of HIF-1alpha in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres.
    Méndez O; Zavadil J; Esencay M; Lukyanov Y; Santovasi D; Wang SC; Newcomb EW; Zagzag D
    Mol Cancer; 2010 Jun; 9():133. PubMed ID: 20515450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal transition and increased therapy resistance of glioblastoma cells is related to astrocyte reactivity.
    Niklasson M; Bergström T; Jarvius M; Sundström A; Nyberg F; Haglund C; Larsson R; Westermark B; Segerman B; Segerman A
    J Pathol; 2019 Nov; 249(3):295-307. PubMed ID: 31298733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide methylomic and transcriptomic analyses identify subtype-specific epigenetic signatures commonly dysregulated in glioma stem cells and glioblastoma.
    Pangeni RP; Zhang Z; Alvarez AA; Wan X; Sastry N; Lu S; Shi T; Huang T; Lei CX; James CD; Kessler JA; Brennan CW; Nakano I; Lu X; Hu B; Zhang W; Cheng SY
    Epigenetics; 2018; 13(4):432-448. PubMed ID: 29927689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and Characterization of Fast-Migrating Human Glioma Cells in the Progression of Malignant Gliomas.
    Adamski V; Schmitt AD; Flüh C; Synowitz M; Hattermann K; Held-Feindt J
    Oncol Res; 2017 Mar; 25(3):341-353. PubMed ID: 27641619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment and External Validation of a Hypoxia-Derived Gene Signature for Robustly Predicting Prognosis and Therapeutic Responses in Glioblastoma Multiforme.
    Wang K; Lu Y; Liu Z; Diao M; Yang L
    Biomed Res Int; 2022; 2022():7858477. PubMed ID: 35155681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing hypoxia-inducible factor-1alpha inhibits cell migration and invasion under hypoxic environment in malignant gliomas.
    Fujiwara S; Nakagawa K; Harada H; Nagato S; Furukawa K; Teraoka M; Seno T; Oka K; Iwata S; Ohnishi T
    Int J Oncol; 2007 Apr; 30(4):793-802. PubMed ID: 17332917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells.
    Maciaczyk D; Picard D; Zhao L; Koch K; Herrera-Rios D; Li G; Marquardt V; Pauck D; Hoerbelt T; Zhang W; Ouwens DM; Remke M; Jiang T; Steiger HJ; Maciaczyk J; Kahlert UD
    Br J Cancer; 2017 Jun; 117(1):102-112. PubMed ID: 28571041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SLC7A11 Overexpression in Glioblastoma Is Associated with Increased Cancer Stem Cell-Like Properties.
    Polewski MD; Reveron-Thornton RF; Cherryholmes GA; Marinov GK; Aboody KS
    Stem Cells Dev; 2017 Sep; 26(17):1236-1246. PubMed ID: 28610554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIF1α regulates single differentiated glioma cell dedifferentiation to stem-like cell phenotypes with high tumorigenic potential under hypoxia.
    Wang P; Lan C; Xiong S; Zhao X; Shan Y; Hu R; Wan W; Yu S; Liao B; Li G; Wang J; Zou D; Chen B; Feng H; Wu N
    Oncotarget; 2017 Apr; 8(17):28074-28092. PubMed ID: 28427209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation.
    Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; DePinho RA
    Nature; 2008 Oct; 455(7216):1129-33. PubMed ID: 18948956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.